Consultant
Improved Pharma
Susan Bogdanowich-Knipp, PhD, currently holds positions as a scientific consultant with Improved Pharma and as president and consultant of Ravine Pharmaceuticals, LLC since 2020. She has extensive expertise in the pre-formulation arena for both small and large molecules and has worked with numerous businesses ranging from virtual companies to large pharmaceutical corporations. Dr. Bogdanowich-Knipp’s previous experience includes having held high profile scientific positions in both widely-recognized large pharmaceutical and outsourcing companies for over twenty-five years. Most recently, she was the Director of Analytical Technology at AMRI SSCI LLC where she was responsible for supporting SSCI’s well-known solid state analytical characterization testing for the site. Addtional previous experience includes scientific positions in Discovery Support & Pharmaceutical Chemistry at Schering-Plough Research Institute and Analytical R&D at Bristol-Myers Squibb Corporation where Dr. Bogdanowich-Knipp supported pre-formulation, development, and both chemical and physical analytical characterization for drug substances and drug products ranging from discovery to Phase II clinical studies for both small and large drug molecules. Dr. Bogdanowich-Knipp holds a Bachelor’s Degree in Chemistry from Douglass College-Rutgers University, both a Masters and a Doctorate degree in Pharmaceutical Chemistry from the University of Kansas and has completed post-doctoral research in Pharmaceutical Chemistry from the University of Kansas.